Marc Semigran - Net Worth and Insider Trading

Marc Semigran Net Worth

The estimated net worth of Marc Semigran is at least $0 dollars as of 2024-11-13. Marc Semigran is the Chief Medical Officer of MyoKardia Inc and owns about 0 shares of MyoKardia Inc (MYOK) stock worth over $0. Details can be seen in Marc Semigran's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marc Semigran has not made any transactions after 2018-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Marc Semigran

Marc Semigran Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marc Semigran owns 6 companies in total, including MyoKardia Inc (MYOK) , Renovacor Inc (RCOR) , and Social Capital Suvretta Holdings Corp III (DNAC) among others .

Click here to see the complete history of Marc Semigran’s form 4 insider trades.

Insider Ownership Summary of Marc Semigran

Ticker	Comapny	Transaction Date	Type of Owner
MYOK	MyoKardia Inc	2019-02-08	Chief Medical Officer
RCOR	Renovacor Inc	2021-09-02	Chief Medical Officer
DNAC	Social Capital Suvretta Holdings Corp III	2021-06-29	director
		2021-06-29	director
		2022-12-19	Chief Development Officer
		2021-09-02	Chief Medical Officer

Marc Semigran Latest Holdings Summary

Marc Semigran currently owns a total of 1 stock. Marc Semigran owns 0 shares of MyoKardia Inc (MYOK) as of September 5, 2018, with a value of $0.

Latest Holdings of Marc Semigran

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MYOK	MyoKardia Inc	2018-09-05	0	224.91	0

Holding Weightings of Marc Semigran

Marc Semigran Form 4 Trading Tracker

According to the SEC Form 4 filings, Marc Semigran has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the sale of 45,000 shares on September 5, 2018, which brought Marc Semigran around $3 Million.

Insider Trading History of Marc Semigran

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marc Semigran Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Marc Semigran Ownership Network

Ownership Network List of Marc Semigran

No Data

Ownership Network Relation of Marc Semigran

Marc Semigran Owned Company Details

What does MyoKardia Inc do?

Who are the key executives at MyoKardia Inc?

Marc Semigran is the Chief Medical Officer of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .

MyoKardia Inc (MYOK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

MyoKardia Inc Insider Transactions

No Available Data

What does Renovacor Inc do?

Who are the key executives at Renovacor Inc?

Marc Semigran is the Chief Medical Officer of Renovacor Inc. Other key executives at Renovacor Inc include Chief Accounting Officer Joseph S Carroll , Chief Financial Officer Frederick W Driscoll , and director & Chief Executive Officer Magdalene Cook .

Renovacor Inc (RCOR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Renovacor Inc (RCOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Renovacor Inc (RCOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Renovacor Inc (RCOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Renovacor Inc Insider Transactions

No Available Data

What does Social Capital Suvretta Holdings Corp III do?

Who are the key executives at Social Capital Suvretta Holdings Corp III?

Marc Semigran is the director of Social Capital Suvretta Holdings Corp III. Other key executives at Social Capital Suvretta Holdings Corp III include 10 percent owner Control Empresarial De Capitales S.a. De C.v. , 10 percent owner Sc Pipe Holdings Llc , and 10 percent owner Tolerantia, Llc .

Social Capital Suvretta Holdings Corp III (DNAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Social Capital Suvretta Holdings Corp III (DNAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Social Capital Suvretta Holdings Corp III (DNAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Social Capital Suvretta Holdings Corp III (DNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Social Capital Suvretta Holdings Corp III Insider Transactions

No Available Data

What does ProKidney Corp do?

Who are the key executives at ProKidney Corp?

Marc Semigran is the director of ProKidney Corp. Other key executives at ProKidney Corp include SVP of Regulatory Development Darin J. Weber , director & 10 percent owner Pablo G. Legorreta , and 10 percent owner Control Empresarial De Capitales S.a. De C.v. .

ProKidney Corp (PROK) Insider Trades Summary

Over the past 18 months, Marc Semigran made no insider transaction in ProKidney Corp (PROK). Other recent insider transactions involving ProKidney Corp (PROK) include a net sale of 13,273,000 shares made by Chamath Palihapitiya , a net sale of 170,593 shares made by Darin J. Weber , and a net purchase of 8,441,462 shares made by Control Empresarial De Capitales S.a. De C.v. .

In summary, during the past 3 months, insiders sold 16,412 shares of ProKidney Corp (PROK) in total and bought 0 shares, with a net sale of 16,412 shares. During the past 18 months, 13,443,593 shares of ProKidney Corp (PROK) were sold and 31,059,371 shares were bought by its insiders, resulting in a net purchase of 17,615,778 shares.

ProKidney Corp (PROK)'s detailed insider trading history can be found in Insider Trading Tracker table.

ProKidney Corp Insider Transactions

No Available Data

What does Edgewise Therapeutics Inc do?

Who are the key executives at Edgewise Therapeutics Inc?

Marc Semigran is the Chief Development Officer of Edgewise Therapeutics Inc. Other key executives at Edgewise Therapeutics Inc include General Counsel John R Moore , CMO Joanne M. Donovan , and Chief Financial Officer R Michael Carruthers .

Edgewise Therapeutics Inc (EWTX) Insider Trades Summary

Over the past 18 months, Marc Semigran made no insider transaction in Edgewise Therapeutics Inc (EWTX). Other recent insider transactions involving Edgewise Therapeutics Inc (EWTX) include a net sale of 111,210 shares made by John R Moore , a net sale of 249,161 shares made by Alan J Russell , and a net sale of 217,249 shares made by R Michael Carruthers .

In summary, during the past 3 months, insiders sold 320,244 shares of Edgewise Therapeutics Inc (EWTX) in total and bought 0 shares, with a net sale of 320,244 shares. During the past 18 months, 645,402 shares of Edgewise Therapeutics Inc (EWTX) were sold and 919,947 shares were bought by its insiders, resulting in a net purchase of 274,545 shares.

Edgewise Therapeutics Inc (EWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Edgewise Therapeutics Inc Insider Transactions

No Available Data

What does Chardan Healthcare Acquisition 2 Corp do?

Who are the key executives at Chardan Healthcare Acquisition 2 Corp?

Marc Semigran is the Chief Medical Officer of Chardan Healthcare Acquisition 2 Corp. Other key executives at Chardan Healthcare Acquisition 2 Corp include Chief Accounting Officer Joseph S Carroll , Chief Financial Officer Frederick W Driscoll , and director & Chief Executive Officer Magdalene Cook .

Chardan Healthcare Acquisition 2 Corp (CHAQ.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chardan Healthcare Acquisition 2 Corp (CHAQ.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chardan Healthcare Acquisition 2 Corp (CHAQ.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chardan Healthcare Acquisition 2 Corp (CHAQ.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chardan Healthcare Acquisition 2 Corp Insider Transactions

No Available Data

Marc Semigran Mailing Address

Above is the net worth, insider trading, and ownership report for Marc Semigran. You might contact Marc Semigran via mailing address: C/o Myokardia, Inc., 333 Allerton Ave, South San Francisco Ca 94080.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.